OpenRx Open Medications Explorer
© 2026 OpenRx · public-domain U.S. government data
On this page

Novolog

insulin aspart

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Novolog
Proper name
insulin aspart
Licence type
351(a)
BLA number
020986
Applicant
Novo Nordisk Inc.
Center
CDER
Presentations
5
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
1,000UNITS/10ML (100UNITS/ML) Injection Intravenous, Subcutaneous Multi-Dose Vial Rx June 7, 2000
300UNITS/3ML (100UNITS/ML) Injection Subcutaneous Multi-Dose Cartridge Rx June 7, 2000
300UNITS/3ML (100UNITS/ML) Injection Subcutaneous Autoinjector Rx January 19, 2001
300UNITS/3ML (100UNITS/ML) Injection Subcutaneous Autoinjector Disc April 23, 2004
300UNITS/3ML (100UNITS/ML) Injection Subcutaneous Autoinjector Disc October 31, 2013

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity